Procter & Gamble revenue misses estimates as volume stays unchanged — SkimNews
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Procter & Gamble reported Q4 revenue of $21.2B, missing Wall Street's $21.38B estimate, while adjusted EPS of $1.43 beat the $1.41 expected — shares fell roughly 3% in morning trading.
- P&G's organic revenue was unchanged with flat volume across its entire portfolio; fiscal year 2026 saw volume growth in just one of four quarters.
- The beauty division (Pantene, Olay, SK-II) led all segments with 3% volume growth, while health care (Oral-B, Vicks) was the worst performer, shrinking 3% on declining oral care sales.
- CFO Andre Schulten blamed 'trade dynamics in the U.S. and the spike in input costs' for headline results and signaled heavier media spending as the company navigates fragmented channels and AI-powered shopping agents.
- P&G projected fiscal 2027 core EPS of $6.89-$7.11 and all-in sales growth of 1-3%, bracing for a $1 billion after-tax headwind from raw materials, energy, and transportation — an estimated 56-cent (8%) drag on EPS.
- CEO Shailesh Jejurikar will add the board chair role effective Aug. 1, replacing former CEO Jon Moeller.
Why it matters: P&G faces a $1 billion after-tax cost headwind for fiscal 2027, dragging EPS by an estimated 56 cents (8%). Its 1-3% sales growth guide brackets the 2.7% analysts expected on the downside, as value-conscious shoppers stretching product lifespans continue to squeeze demand — flat volume in three of four fiscal 2026 quarters shows the pressure isn't letting up.
Ask SkimNews
